Industrial Machinery & Robotics Global On demand · 24-48h

Global Microplates Market Strategic Research Report

Global Microplates Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Microplates Market
$6952025
2.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 24-Well, 48-Well, 96-Well, 384-Well, Others

By Application: Medical and Testing Institutions, Pharmaceutical Companies, Scientific Research Institutions

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Corning, Eppendorf, VWR, Qiagen, Greiner Bio-One, Agilent Technologies, Zhejiang Gongdong Medical Technology, Shenzhen Changhong Technology, Wuxi NEST Biotechnology, Guangzhou JET Bio-Filtration Products Co., Ltd., Shanghai Titan Technology Co., Ltd., Beyotime Biotech Inc., Beaverbio, Hellma Holding GmbH, Merck, GE Healthcare, SPL Life Sciences Co., Ltd., Berthold Technologies GmbH & Co. KG

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 126 pages
Market size 2025
$695
Million USD
Forecast CAGR
2.4%
2025-2032
Forecast 2032
$820.5
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Microplates market size is predicted to grow from US$ 695 million in 2025 to US$ 821 million in 2032; it is expected to grow at a CAGR of 2.4% from 2026 to 2032.

Microplates are a detection laboratory consumable that has become a standard tool in analytical research and clinical diagnostic testing laboratories. One common use is enzyme-linked immunosorbent assay (ELISA), which is the basis of most modern medical diagnostic tests in humans and animals. Microplates typically have 6, 12, 24, 48, 96, 384, or 1536 sample well arranged in a 2:3 rectangular matrix. Each well of a microplate typically holds tens of nanoliters to a few milliliters of liquid. Today, microplates are used for nearly all applications in life science research, including filtration, separation, optical detection, storage, reaction mixing, cell culture, and detection of antimicrobial activity. The earliest microplates were created by Hungarian Dr. Gyula Takatsy in 1951, and general use began in the late 1980s when Jhnliner introduced molded versions. By 1990, there were more than 15 companies producing a variety of microplates with different functions.In 1996, the Society for Biomolecular Screening (SBS) set out to create a standard definition of microplates. A series of standards was proposed in 2003 and published by the American National Standards Institute (ANSI) on behalf of SBS. The standard governs various characteristics of microplates, including well size as well as microplate characteristics, allowing interoperability between microplates, instruments and devices from different suppliers, especially important in laboratory automation, 2010, The Association for Biomolecular Sciences and the Association for Laboratory Automation (ALA) have merged to form a new organization, the Association for Laboratory Automation and Screening (SLAS). Hereafter, the microplate standard is known as the ANSI/SLAS standard. The production and manufacturing of microplates in China started relatively late and is still in the initial stage of development. Most enterprises have small production scales, slightly rough production processes, poor independent research and development capabilities, and uneven product quality. Under the characteristics of this industry, leading enterprises have become industry standard setters through technological innovation, production process innovation, and marketing model innovation. Leading enterprises have always been in an active position in terms of product performance, cost control, and market development through their first-mover advantages in R&D technology, large-scale production, marketing channels, and financial strength, thus leading the development direction of the industry.

In China, the key players of microplates include Thermo Fisher Scientific, Corning, Eppendorf, VWR, Qiagen, etc. The top five players hold a share about 65% of China market. In terms of product type, 96-well is the largest segment, occupied for a share of 76%, and in terms of application, pharmaceutical companies has a share about 48 percent.

This report presents a comprehensive overview of the global Microplates market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • 24-Well
  • 48-Well
  • 96-Well
  • 384-Well
  • Others

Segment by Application

  • Medical and Testing Institutions
  • Pharmaceutical Companies
  • Scientific Research Institutions

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Microplates market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Medical and Testing Institutions, Pharmaceutical Companies, Scientific Research Institutions evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Microplates Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 2.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$695
2025
Forecast
$820.5
2032
CAGR
2.4%
2025–2032
Regions
5
global
Key companies
Thermo Fisher ScientificCorningEppendorfVWRQiagenGreiner Bio-OneAgilent TechnologiesZhejiang Gongdong Medical Technology
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
24-Well48-Well96-Well384-WellOthers
By Application
Medical and Testing InstitutionsPharmaceutical CompaniesScientific Research Institutions

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 24-Well
  • 3.1.3 48-Well
  • 3.1.4 96-Well
  • 3.1.5 384-Well
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Medical and Testing Institutions
  • 4.1.3 Pharmaceutical Companies
  • 4.1.4 Scientific Research Institutions
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Corning
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Eppendorf
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 VWR
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Qiagen
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Greiner Bio-One
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Agilent Technologies
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Zhejiang Gongdong Medical Technology
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Shenzhen Changhong Technology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Wuxi NEST Biotechnology
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Guangzhou JET Bio-Filtration Products Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Shanghai Titan Technology Co., Ltd.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Beyotime Biotech Inc.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Beaverbio
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Hellma Holding GmbH
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Merck
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 GE Healthcare
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 SPL Life Sciences Co., Ltd.
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Berthold Technologies GmbH & Co. KG
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Microplates market size?
The global Microplates market is estimated at US$ 695 million in 2025 (base year) and is projected to reach US$ 821 million by 2032.
What growth rate is expected for the Microplates market through 2032?
The market is expected to grow at a CAGR of 2.4% from 2026 to 2032, expanding from US$ 695 million in 2025 to US$ 821 million in 2032, roughly 1.2 times its base-year value.
How is Microplates defined?
Microplates are a detection laboratory consumable that has become a standard tool in analytical research and clinical diagnostic testing laboratories. One common use is enzyme-linked immunosorbent assay (ELISA), which is the basis of most modern medical diagnostic tests in humans and animals. Microplates typically have 6, 12, 24, 48, 96, 384, or 1536 sample well arranged in a 2:3 rectangular matrix.
What are the main segments of the Microplates market by type?
By type, the market is segmented into 24-Well, 48-Well, 96-Well, 384-Well and Others.
Which applications drive demand in the Microplates market?
Key applications covered include Medical and Testing Institutions, Pharmaceutical Companies and Scientific Research Institutions.
Who are the key players in the Microplates market?
Key players profiled include Thermo Fisher Scientific, Corning, Eppendorf, VWR, Qiagen, Greiner Bio-One, Agilent Technologies and Zhejiang Gongdong Medical Technology, among 19 companies covered in total.
Which regions and countries are covered for Microplates?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Microplates market report?
The report is intended for manufacturers and solution providers, distributors and end users in Medical and Testing Institutions, Pharmaceutical Companies and Scientific Research Institutions, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Microplates market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.